Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials

OBJECTIVE: To review the comparative effectiveness of osteoporosis treatments, including the bone anabolic agents, abaloparatide and romosozumab, on reducing the risk of fractures in postmenopausal women, and to characterise the effect of antiosteoporosis drug treatments on the risk of fractures acc...

Descripción completa

Detalles Bibliográficos
Autores principales: Händel, Mina Nicole, Cardoso, Isabel, von Bülow, Cecilie, Rohde, Jeanett Friis, Ussing, Anja, Nielsen, Sabrina Mai, Christensen, Robin, Body, Jean-Jacques, Brandi, Maria Luisa, Diez-Perez, Adolfo, Hadji, Peyman, Javaid, Muhammad Kassim, Lems, Willem Frederik, Nogues, Xavier, Roux, Christian, Minisola, Salvatore, Kurth, Andreas, Thomas, Thierry, Prieto-Alhambra, Daniel, Ferrari, Serge Livio, Langdahl, Bente, Abrahamsen, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152340/
https://www.ncbi.nlm.nih.gov/pubmed/37130601
http://dx.doi.org/10.1136/bmj-2021-068033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152340/
https://www.ncbi.nlm.nih.gov/pubmed/37130601
http://dx.doi.org/10.1136/bmj-2021-068033

Ejemplares similares